10 Best Cheapest Stocks To Own For 2014

Bank stocks were the last place any investor wanted to be during the financial crisis. However, as balance sheets have improved, bank stocks have gone on an impressive run. Despite the recent gains, many of the big banks are still trading at deep discounts when compared to their historical valuations.

In this video, Motley Fool banking analysts Matt Koppenheffer and David Hanson identify which banks are the cheapest and debate how much upside these megabanks have over the next five years.�

Bank of America's stock doubled in 2012. Is there more yet to come? With significant challenges still ahead, it's critical to have a solid understanding of this megabank before adding it to your portfolio. In The Motley Fool's premium research report on B of A, analysts Anand Chokkavelu, CFA, and Matt Koppenheffer, Financials bureau chief, lift the veil on the bank's operations, including detailing three reasons to buy and three reasons to sell. Click here now to claim your copy.

Top 10 Penny Stocks To Own For 2015: Lojas Renner SA (LREN3)

Lojas Renner SA is a Brazil- based company primarily involved in the operation of department stores. The Company divides its business into two segments. The Retail segment is engaged in sale of women's, men's and children's apparels, underwear and shoes, as well as sportswear and other department stores' articles in the domestic market. The Company also sells household articles, bedding and bath items, furniture and decoration articles. The Financial products segment is involved in the intermediation of financial services, including brokerage of personal loans, sales financing, brokerage of insurance and bonds, and credit card processing, among others. The Company operates through a numerous subsidiaries, including Dromegon Participacoes Ltda, Renner Administradora de Cartoes de Credito Ltda, Renner Empreendimentos Ltda and Maxmix Comercial Ltda. Advisors' Opinion:

• [By Ney Hayashi]

  Anhanguera Educacional Participacoes SA (AEDU3) tumbled after Brazil�� antitrust regulator signaled it may limit the education company�� merger with competitor Kroton Educacional SA. (KROT3) Lojas Renner SA (LREN3) led retailers higher after a report showed Brazil�� industrial production expanded faster than expected in October, easing concern that growth is faltering.

10 Best Cheapest Stocks To Own For 2014: Tokyo Electron Ltd (TOELY.PK)

Tokyo Electron Limited is a company mainly engaged in the manufacture and sale of electronic products for industrial uses. The Semiconductor Manufacturing Equipment, Flat-panel Display (FPD) and Photovoltaic Cell (PV) Manufacturing Equipment segment provides coaters and developers for wafer processing, plasma etching equipment, thermal processing systems, single wafer deposition systems, cleaning systems, coaters and developers for FPD manufacturing, ashing devices and plasma chemical vapor deposition (CVD) devices. The Electronic Component and Information Communication Equipment segment designs, develops, purchases and sells semiconductor products such as integrated circuits (ICs), computer and network equipment and software. The Others segment involves in logistics, facility management and insurance businesses. On April 1, 2013, it merged with two subsidiaries. In January 2014, the Company established TEL-Applied Holdings B.V. and a Japan-based company. Advisors' Opinion:

• [By Stephen Simpson, CFA]

  Ultratech isn't the only game in town, though, and there are multiple technologies and process steps that are going to play significant roles in the production of FinFETs and 3D circuits. With that, I would take a look at Mattson Technologies (MTSN), as this company has already accomplished the not-so-easy task of gaining meaningful share in the dry strip, rapid thermal processing (RTP), and etch markets despite competing with giants like Lam Research (LRCX), Applied Materials (AMAT), and Tokyo Electron (TOELY.PK).

10 Best Cheapest Stocks To Own For 2014: Astellas Pharma Inc (ALPMY.PK)

Astellas Pharma Inc. is a Japan-based company mainly engaged in the pharmaceutical business. The Company is involved in the manufacture and sale of pharmaceutical products in Japan, the United States, Europe, China, Korea and Taiwan, through its subsidiaries. Its main products include immunosuppressive drug Prograf, overactive bladder agent Vesicare, Protopic ointment for atopic dermatitis, Harnal for prostatic and urethral smooth muscle, and antimycotic agent Funguard, among others. It also provides pharmaceutical products for gastritis, chronic hepatitis C, irritable bowel syndrome, osteoporosis, hypertension, schizophrenia, rheumatoid arthritis, agrypnia, atopic dermatitis and other diseases. Advisors' Opinion:

• [By Henry Kawabe]

  Seattle Genetic is currently collaborating on 22 different ADC drug trials in various stages of testing with twelve different pharmaceutical companies, including nine with Genentech (RHHBY.OB), two with AbbVie (ABBV), two with Agensys (ALPMY.PK), and one with Pfizer (PFE). To date, these ADC collaborations have generated more than $225 million for Seattle Genetics and have the potential to generate more than $3.5 billion in milestone payments plus royalties.

10 Best Cheapest Stocks To Own For 2014: JMP Group Inc (JMP)

JMP Group Inc., through its subsidiaries, operates as an investment banking, asset management, and corporate credit management company in the United States. The company provides various investment banking products and services, such as capital raising, mergers and acquisitions transaction, and other strategic advisory services to corporate clients. It also offers sales and trading services, which include distributing equity research products, communicating proprietary investment recommendations, executing equity trades on behalf of institutional clients, and marketing the securities of companies, as well as related brokerage services to institutional investors. In addition, the company provides proprietary equity research in five industries, including consumer, financial services, healthcare, real estate, and technology industries. Further, it provides asset management products and services to institutional investors, and high net-worth individuals; and involves in the man agement of collateralized loan obligations. JMP Group Inc. was founded in 1999 and is headquartered in San Francisco, California with additional offices in New York, New York; Boston, Massachusetts; Chicago, Illinois; and Alpharetta, Georgia.

Advisors' Opinion:

• [By Marc Bastow]

  Full-service investment banking, asset management and corporate credit management firm JMP Group (JMP) raised its quarterly dividend 13% to 4.5 cents per share, payable April 11 to shareholders of record as of March 28.
  JMP Dividend Yield: 2.41%

10 Best Cheapest Stocks To Own For 2014: Infinity Pharmaceuticals Inc.(INFI)

Infinity Pharmaceuticals, Inc. engages in the discovery and development of medicines for difficult-to-treat diseases. The company?s lead product candidates include saridegib (IPI-926), an oral molecule with the potential to treat a range of cancers by disrupting malignant activation of the Hedgehog pathway; and Retaspimycin HCl (IPI-504), a heat shock protein 90 (Hsp90) inhibitor. Its Saridegib is in a Phase II clinical trial for the treatment of metastatic or inoperable chondrosarcoma and a Phase II exploratory trial in patients with myelofibrosis. The company?s Retaspimycin HCl is in a Phase II trial in combination with docetaxel to treat patients with non-small cell lung cancer (NSCLC); and in a Phase Ib/II trial in combination with everolimus, known as Afinitor, in approximately 45 NSCLC patients with a KRAS mutation. Its pipeline also includes IPI-145, an inhibitor of the delta and gamma isoforms of phosphoinositide-3-kinase (PI3K) in Phase I development to treat in flammation and hematologic malignancies. Infinity Pharmaceuticals has a strategic alliance with Purdue Pharmaceutical Products L.P. and Mundipharma International Corporation Limited to develop and commercialize pharmaceutical products; and a development and license agreement with Millennium to discover, develop, and commercialize pharmaceutical products targeting the delta and/or gamma isoforms of PI3K, including IPI-145. Purdue Pharmaceutical Products is planning to conduct Phase II studies of IPI-940 in pain. The company is headquartered in Cambridge, Massachusetts.

Advisors' Opinion:

• [By Luke Jacobi]

  Infinity Pharmaceuticals (NASDAQ: INFI) shares shot up 44.1 percent to $15.73 on deal with AbbVie (NYSE: ABBV).

  Shares of Concur Technologies (NASDAQ: CNQR) got a boost, shooting up 8.6 percent to $109.60 following a Bloomberg TV report that the company may be exploring a possible sale.

10 Best Cheapest Stocks To Own For 2014: Texas Industries Inc (TXI)

Texas Industries, Inc., incorporated on April 19, 1951, is a supplier of construction materials in the southwestern United States. The Company operates in three segments: cement, aggregates and consumer products. Its cement segment produces gray portland cement and specialty cements. The Company�� cement production and distribution facilities are concentrated primarily in Texas and California. Its aggregates segment produces natural aggregates, including sand, gravel and crushed limestone. The Company�� consumer products segment produces ready-mix concrete. It is also a supplier of natural aggregates and ready-mix concrete in Texas and northern Louisiana and in Oklahoma and Arkansas. As of May 31, 2013, the Company had 123 manufacturing facilities in five states.

Cement Segment

The Company produces specialty cements, such as masonry and oil well cements. Its cement production facilities are located at Midlothian, Texas, south of Dallas/Fort Worth, Hunter, Texas, between Austin and San Antonio, and Oro Grande, California, near Los Angeles. It also operates a cement terminal and packaging facility at its Crestmore plant near Riverside, California, and the Company operates its gray portland cement grinding facility on an as needed basis. During the fiscal year ended May 31, 2013 (fiscal 2013), it produced approximately 4.3 million tons of finished cement. The Company shipped approximately 4.4 million tons during fiscal 2013, of which 3.8 million tons were shipped to outside trade customers.

Aggregates Segment

The Company�� operations are conducted from facilities primarily serving the Dallas/Fort Worth and Austin areas in Texas; the southern Oklahoma area, and the Alexandria and Monroe areas in Louisiana. The Company produced approximately 14.2 million tons of natural aggregates during fiscal 2013. It shipped approximately 14.8 million tons of natural aggregates during fiscal 2013, of which 11.3 million tons were shipped to outside trade customers! . The Company shipped approximately 1.0 million cubic yards of lightweight aggregates during fiscal 2013, of which approximately 0.9 million cubic yards were shipped to outside trade customers.

Consumer Products Segment

The Company�� ready-mix concrete operations are situated in three areas in Texas (the Dallas/Fort Worth/Denton area of north Texas, the Austin area of central Texas and from Beaumont to Texarkana in east Texas), in north and central Louisiana, and in southwestern Arkansas. It is also a 40% partner in a joint venture that has ready mix concrete operations in the northern part of central Texas area centered around Waco, Texas. It shipped approximately 2.8 million cubic yards of ready-mix concrete during fiscal 2013. The Company manufacture and supply a substantial amount of the cement and aggregates raw materials used by our ready-mix plants. The Company also marketed its Maximizer packaged concrete mixes in southern California.

Advisors' Opinion:

• [By Monica Gerson]

  Texas Industries (NYSE: TXI) is expected to post its Q1 earnings at $0.01 per share on revenue of $233.63 million.

  National American University Holdings (NASDAQ: NAUH) is projected to post a Q1 loss at $0.01 per share on revenue of $30.58 million.

10 Best Cheapest Stocks To Own For 2014: China Nepstar Chain Drugstore Ltd (NPD)

China Nepstar Chain Drugstore Ltd. operates retail drugstores in the People?s Republic of China. The company?s drugstores provide pharmacy services and other merchandise, including prescription drugs; over-the-counter drugs; nutritional supplements, such as healthcare supplements, vitamins, minerals, and dietary products; herbal products, including drinkable herbal remedies and packages of assorted herbs for making soup; and private label products. Its stores also offer personal care products, such as skin care, hair care, and beauty products; family care products, including portable medical devices for family use, birth control products, and early pregnancy test products; and convenience products, such as soft drinks, packaged snacks, other consumables, cleaning agents, and stationeries, as well as seasonal and promotional items. The company operates its stores under the China Nepstar brand name. As of December 31, 2009, its store network comprised 2,479 retail drugstores located in approximately 71 cities in Guangdong, Jiangsu, Zhejiang, Liaoning, Shandong, Hunan, Fujian, Sichuan, and Hubei provinces, as well as in Shanghai, Tianjin, and Beijing municipalities of the People?s Republic of China. The company was founded in 1995 and is headquartered in Shenzhen, the People?s Republic of China.

Advisors' Opinion:

• [By Garrett Cook]

  Non-cyclical consumer goods & services shares dropped around 0.20 percent in today’s trading. Top decliners in the sector included K12 (NYSE: LRN), China Nepstar Chain Drugstore (NYSE: NPD), and Du Pont (NYSE: DD).